Insights into the limitations of transient expression systems for the functional study of p53 acetylation site and oncogenic mutants

Biochem Biophys Res Commun. 2020 Apr 16;524(4):990-995. doi: 10.1016/j.bbrc.2020.02.002. Epub 2020 Feb 12.

Abstract

Tumor suppressor protein p53 protects cells against malignant transformation mostly through transcriptional activation. Lysine acetylation is required to mediate activation of p53. The protein displays eight lysine residues and their evolutionary conservation argues for an essential role. The aim of this study was to investigate the significance of individual acetylation sites in mediating p53 functions. Differences in intracellular localization, protein expression levels, and transcriptional activity were investigated by overexpressing acetylation-deficient p53 variants in the colon carcinoma-derived p53 knock-out cell line HCT 116 p53(-/-). We found that not all lysine residues are equally capable of promoting p53's functions. Individual amino acid mutations or combinations thereof led to altered p53 expression levels, intracellular distribution, or transcriptional transactivation capacity, as compared to the wild-type protein. However, we observed that the choice of protein tag and expression vector could significantly alter obtained results on certain aspects of p53 function.

Keywords: Lysine acetylation; Mutation; TP53; Tumor suppressor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Colonic Neoplasms / genetics*
  • HCT116 Cells
  • Humans
  • Lysine / analysis
  • Lysine / genetics
  • Mutagenesis
  • Mutation*
  • Transcriptional Activation
  • Tumor Suppressor Protein p53 / analysis
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • Lysine